|
[1]
|
Fanouriakis, A., Kostopoulou, M., Cheema, K., et al. (2020) 2019 Update of the Joint European League against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) Recommendations for the Management of Lupus Nephritis. Annals of the Rheumatic Diseases, 79, 713-723.
|
|
[2]
|
Yu, C., Li, P., Dang, X., Zhang, X., Mao, Y. and Chen, X. (2022) Lupus Nephritis: New Progress in Diagnosis and Treatment. Journal of Autoimmunity, 132, Article ID: 102871. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Aringer, M., Costenbader, K., Daikh, D., et al. (2019) 2019 European League against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 78, 1151-1159.
|
|
[4]
|
中国狼疮肾炎诊断和治疗指南编写组. 中国狼疮肾炎诊断和治疗指南[J]. 中华医学杂志, 2019, 99(44): 3441-3455.
|
|
[5]
|
Yamamoto, E.A. and Jørgensen, T.N. (2020) Relationships between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Frontiers in Immunology, 10, Article No. 3141. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Durcan, L., O’Dwyer, T. and Petri, M. (2019) Management Strategies and Future Directions for Systemic Lupus Erythematosus in Adults. The Lancet, 393, 2332-2343. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Gasparotto, M., Gatto, M., Binda, V., Doria, A. and Moroni, G. (2020) Lupus Nephritis: Clinical Presentations and Outcomes in the 21st Century. Rheumatology, 59, v39-v51. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Islam, M.A., Khandker, S.S., Alam, S.S., Kotyla, P. and Hassan, R. (2019) Vitamin D Status in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Review and Meta-Analysis. Autoimmunity Reviews, 18, Article ID: 102392. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Leventis, P. and Patel, S. (2008) Clinical Aspects of Vitamin D in the Management of Rheumatoid Arthritis. Rheumatology, 47, 1617-1621. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Zhang, X., Guo, Q., Sun, S., Tang, X., Shen, W., Liang, J., et al. (2023) Factors Associated with 25-Hydroxyvitamin D Level in Chinese Hospitalized Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study. Rheumatology International, 44, 2067-2078. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
邹健梅, 武丽君, 罗采南, 等. 血清25-羟维生素D与系统性红斑狼疮活动的关系[J]. 北京大学学报(医学版), 2021, 53(5): 938-941.
|
|
[12]
|
张喜梅, 刘鑫阔, 彭亮. 血清D-二聚体、胱抑素C水平与狼疮性肾炎患者预后的关系研究[J]. 医学理论与实践, 2023, 36(23): 4073-4076.
|
|
[13]
|
王坤, 赵玉荣, 陈瑞, 等. 系统性红斑狼疮患者血清D-二聚体、补体C3、清蛋白、超氧化物歧化酶水平与病情活动度的关联性[J]. 国际检验医学杂志, 2022, 43(10): 1158-1161.
|
|
[14]
|
Mahajan, A., Amelio, J., Gairy, K., Kaur, G., Levy, R.A., Roth, D., et al. (2020) Systemic Lupus Erythematosus, Lupus Nephritis and End-Stage Renal Disease: A Pragmatic Review Mapping Disease Severity and Progression. Lupus, 29, 1011-1020. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Jenkins, P.V. and O’Donnell, J.S. (2006) ABO Blood Group Determines Plasma Von Willebrand Factor Levels: A Biologic Function after All? Transfusion, 46, 1836-1844. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
柯心雨, 杨定平. 狼疮肾炎患者血清D-二聚体水平与疾病活动度及肾损害的关系[J]. 医学研究杂志, 2021, 50(1): 37-41.
|
|
[17]
|
胥兴丽, 王仁峰. 系统性红斑狼疮早期肾损伤诊断及危险因素分析[J]. 中国实验诊断学, 2021, 25(3): 344-347.
|